RESUMO
Se presenta una revisión sobre la posibilidad terapéutica del empleo de la ferulización entre dientes e implantes. Tras una breve introducción, se establece una serie de diferencias biomecánicas entre dos estructuras tan dispares como son el diente y el implante. Posteriormente, se exponen una serie de puntos que los distintos autores han achacado a este sistema protésico para luego describir los distintos diseños que se pueden aplicar (rígidos y semirrígidos). A continuación, se efectúa una revisión bibliográfica acerca de la evolución a corto y largo plazo de estos sistemas. Por último, se elabora una relación de ventajas, desventajas e indicaciones de la ferulización diente-implante, para terminar estableciendo unas conclusiones (AU)
A review about the tooth-implant splinting therapeutic option is presented. After a brief introduction, it begins with some biomechanical aspects. Then, some critical points about this kind of frames are shown in order to, afterwards; describe de different design that can be applied. A short and long-term evolution of these systems is also made and, finally, we can see some advantages, disadvantages and indications for the splinting option, to finish establishing some conclusions (AU)
Assuntos
Adulto , Humanos , Boca/fisiologia , Ferula/tendências , Ferula , Dente Artificial , Implantes Dentários , Prótese Dentária/métodos , Prótese DentáriaRESUMO
OBJECTIVE: To study the association between the application of a diabetic care programme and modifications in glycated haemoglobin and the Body Mass Index. DESIGN: Descriptive study. SETTING: Two health centres. PATIENTS: 199 patients were studied, the total number of type II diabetics found in three general medicine practices. INTERVENTION: Patients followed, at different levels, a programme of diabetic care. Variation of glycated haemoglobin and the Body Mass Index were measured in each patient during the 1991-1992 period. These were then related to their continuation in the programme and whether they were included in this programme at the moment of the examination. RESULTS: The average drop in glycated haemoglobin was -15.3% (12.2 +/- 18.4) (p < 0.001). Average variation of the Body Mass Index was 0.2% (-0.6 +/- 1.00), not significant. Average drop in glycated haemoglobin in those included was -16% (12.5 +/- 19.5) (p < 0.001) and in those not included, -12.6% (5.3 +/- 19.9) (p < 0.001), no significant difference. The correlation between the degree of continuation in the programme and the variation of glycated haemoglobin had a r = -0.04 (p = 0.7) and between the degree of continuation and variation in the Body Mass Index, a r of 0.15 (p = 0.06). When the initial value of glycated haemoglobin was equal to or above 7.5, its average drop was -22.3% (17.8 +/- 26.9) (p < 0.001). CONCLUSIONS: The drop in glycated haemoglobin is significant and more important, the greater the initial value. But it has not been possible to link it with the level of continuance in the programme nor with whether patients were included in the programme. The Body Mass Index does not vary.
